BR9712168A - Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos. - Google Patents
Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos.Info
- Publication number
- BR9712168A BR9712168A BR9712168-1A BR9712168A BR9712168A BR 9712168 A BR9712168 A BR 9712168A BR 9712168 A BR9712168 A BR 9712168A BR 9712168 A BR9712168 A BR 9712168A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- prevention
- human
- stroke
- processes
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
- 238000000855 fermentation Methods 0.000 title abstract 4
- 230000004151 fermentation Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 235000016709 nutrition Nutrition 0.000 title abstract 4
- 241000282412 Homo Species 0.000 title abstract 3
- 230000036996 cardiovascular health Effects 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 229940057059 monascus purpureus Drugs 0.000 title abstract 3
- 208000000044 Amnesia Diseases 0.000 title abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 206010008132 Cerebral thrombosis Diseases 0.000 title abstract 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000012423 maintenance Methods 0.000 title abstract 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title abstract 2
- 208000004930 Fatty Liver Diseases 0.000 title 1
- 206010019708 Hepatic steatosis Diseases 0.000 title 1
- 208000026139 Memory disease Diseases 0.000 title 1
- 208000006011 Stroke Diseases 0.000 title 1
- 208000010706 fatty liver disease Diseases 0.000 title 1
- 230000006984 memory degeneration Effects 0.000 title 1
- 208000023060 memory loss Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 231100000240 steatosis hepatitis Toxicity 0.000 title 1
- 230000035764 nutrition Effects 0.000 abstract 3
- 239000000047 product Substances 0.000 abstract 3
- 208000008589 Obesity Diseases 0.000 abstract 2
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 206010008479 Chest Pain Diseases 0.000 abstract 1
- 206010008469 Chest discomfort Diseases 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 abstract 1
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 230000004596 appetite loss Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000021266 loss of appetite Nutrition 0.000 abstract 1
- 208000019017 loss of appetite Diseases 0.000 abstract 1
- 231100000863 loss of memory Toxicity 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72054896A | 1996-09-30 | 1996-09-30 | |
| PCT/US1997/017574 WO1998014177A1 (fr) | 1996-09-30 | 1997-09-29 | Procede et compositions mettant en oeuvre des produits de fermentation a base de levure rouge |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712168A true BR9712168A (pt) | 2000-01-18 |
Family
ID=24894390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712168-1A BR9712168A (pt) | 1996-09-30 | 1997-09-29 | Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0932395A1 (fr) |
| JP (1) | JP2001501621A (fr) |
| KR (1) | KR20000048765A (fr) |
| AU (1) | AU4658797A (fr) |
| BR (1) | BR9712168A (fr) |
| CA (1) | CA2267340A1 (fr) |
| HU (1) | HUP9904650A2 (fr) |
| IL (1) | IL129216A0 (fr) |
| WO (1) | WO1998014177A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436406B1 (en) | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
| KR100426880B1 (ko) * | 2002-02-04 | 2004-04-13 | 학교법인 영광학원 | 모나스쿠스 피로수스를 이용한 적색 메주색소의 제조방법 |
| KR20020093147A (ko) * | 2002-05-30 | 2002-12-13 | 지니스생명공학 주식회사 | 성인병 예방 및 치료 보조제 |
| JPWO2004112809A1 (ja) * | 2003-06-24 | 2006-07-20 | 大塚製薬株式会社 | 血清尿酸低減組成物 |
| US20100119600A1 (en) * | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
| TW201038205A (en) * | 2009-04-29 | 2010-11-01 | Sunway Biotech Co Ltd | The compositions of Monascus fermented products with a function that reduces body fatness formation and the method for manufacturing the same |
| JP2010273569A (ja) * | 2009-05-26 | 2010-12-09 | Wasaburo Sato | メタボリックシンドローム改善作用を有する飲料及びサプリメント |
| JP5912361B2 (ja) * | 2011-09-16 | 2016-04-27 | 晨暉生物科技股▲分▼有限公司 | 血液脂質を引き下げ、ｈｄｌコレステロールを引き上げることができる混合物とその製造方法 |
| TWI518094B (zh) | 2011-12-26 | 2016-01-21 | Univ Beijing Peking Wbl Biotech Co Ltd | One kind of derivatives of sterols, their preparation and use |
| CN113171316B (zh) * | 2021-04-23 | 2022-06-14 | 科丝美诗(中国)化妆品有限公司 | 一种修复、缓解皮肤刺激化妆品及制备方法 |
| CN120021515B (zh) * | 2025-03-25 | 2025-11-11 | 浙江省农业科学院 | 缩短栽培周期的优质高产的金耳培养基、配制方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56150037A (en) * | 1980-04-22 | 1981-11-20 | Sankyo Co Ltd | Hydronaphthalene compound |
| JP3168298B2 (ja) * | 1993-02-05 | 2001-05-21 | 有限会社フジ・バイオ研究所 | 紅麹を使用した酒精飲料の製造法 |
-
1997
- 1997-09-29 IL IL12921697A patent/IL129216A0/xx unknown
- 1997-09-29 HU HU9904650A patent/HUP9904650A2/hu unknown
- 1997-09-29 EP EP97945365A patent/EP0932395A1/fr not_active Withdrawn
- 1997-09-29 JP JP10516787A patent/JP2001501621A/ja active Pending
- 1997-09-29 WO PCT/US1997/017574 patent/WO1998014177A1/fr not_active Ceased
- 1997-09-29 CA CA002267340A patent/CA2267340A1/fr not_active Abandoned
- 1997-09-29 BR BR9712168-1A patent/BR9712168A/pt unknown
- 1997-09-29 AU AU46587/97A patent/AU4658797A/en not_active Abandoned
- 1997-09-29 KR KR1019990702751A patent/KR20000048765A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998014177A1 (fr) | 1998-04-09 |
| KR20000048765A (ko) | 2000-07-25 |
| HUP9904650A2 (hu) | 2000-05-28 |
| AU4658797A (en) | 1998-04-24 |
| IL129216A0 (en) | 2000-02-17 |
| EP0932395A1 (fr) | 1999-08-04 |
| JP2001501621A (ja) | 2001-02-06 |
| CA2267340A1 (fr) | 1998-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1044009B8 (fr) | Compositions contenant des produits fermentes a base de riz rouge et procedes associes | |
| US5840715A (en) | Dietary regimen of nutritional supplements for relief of symptoms of arthritis | |
| BR9712168A (pt) | Processos de tratamento ou de prevenção de u distúrbio cardiovascular em um humano, de tratamento ou de prevenção de acidente vascular cerebral, trombose cerebral ou de perda de memória devido ao acidente vascular cerebral, de tratamento ou de prevenção de condições de fìgado gorduroso em um humano, de melhoria ou de manutenção da saúde cardiovascular, de tratamento ou de prevenção de diabetes em um humano e de redução dos nìveis de colesterol e de triglicerìdeo do soro, composição nutricional ou farmacêutica, medicamento, e, produto de fermentação delevedura vermelha adequado para liberação oral em humanos. | |
| BR0214838A (pt) | Composição para promoção de crescimento ósseo e manutenção da saúde óssea | |
| EP1604677A1 (fr) | Composition ayant des effets antioxidants, antinflammatoires et immunostimulants | |
| NZ335086A (en) | Bacillus thuringiensis pesticidal toxins and nucleotide sequences which encode these toxins | |
| CA2240165A1 (fr) | Regime alimentaire a base de complements nutritionnels permettant de soulager les symptomes de l'arthrite | |
| WO2008100130A2 (fr) | Composition contenant de l'extrait de piper sarmentosum (kadok) et du collagène | |
| Obaid | The medical uses of Gum Acacia-Gum Arabic (GA) in human | |
| EP3381457B1 (fr) | Composition physiologique active | |
| CN105942490A (zh) | 一种防治高血脂高血糖高血压的复合酵素组合物 | |
| KR20170139780A (ko) | 혈관 기능을 개선하는데 도움을 주는 서사향이 함유된 조성물 | |
| DE202008015430U1 (de) | Zusammensetzung zur Behandlung von Verdauungsstörungen | |
| CN116616448A (zh) | 含有有机硒的维生素c片及生产工艺 | |
| CN112617206A (zh) | 一种降低炎性细胞因子及调节免疫功能的复合益生菌及其应用 | |
| CN118829360B (zh) | 用于减轻运动之后关节疼痛的胶原蛋白水解物组合物 | |
| KR101866065B1 (ko) | 식물성 식이유황 추출물 제조방법과 이를 함유하는 식초 음료 제조 | |
| CN119949511B (zh) | 一种含有木瓜的药食同源保健品及其应用 | |
| CN1195529A (zh) | 一种治疗跌打损伤的药物及其制备方法 | |
| Khan et al. | Nutraceuticals and their benefits for health: A review | |
| Pizzorno Jr | Natural medicine approach to treating osteoarthritis | |
| WO2002028400A1 (fr) | Formulation therapeutique contenant de la glucosamine, du dimethylsulfone et eventuellement de l'acide ascorbique et du manganese | |
| Xafizova | STUDY OF THE PREVENTIVE EFFECTS OF HERBAL PREPARATIONS, SUCH AS BURDOCK ROOT, ON GASTROINTESTINAL HEALTH | |
| TW202135835A (zh) | 用於促進硫酸軟骨素合成之組成物 | |
| CN1094960A (zh) | 膨化鱼药及其生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A , 5A , 6A , 7A E 8A ANUIDADES. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: C12R 1/645 (2006.01), A23L 33/105 (2016.0 |